The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Coding Corner Questions: Using NP/PA Services in Practice

Coding Corner Questions: Using NP/PA Services in Practice

February 13, 2020 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Scenario 1: Direct Billing

You Might Also Like
  • Coding Corner Answers: Using NP/PA Services in Practice
  • Coding Corner Question: March
  • Rheumatology Coding Corner Question: Infusion Services for Skilled Nursing Facility Patient
Explore This Issue
February 2020
Also By This Author
  • Fiscal Year 2022 ICD-10-CM Codes Now in Effect

A 70-year-old female patient with rheumatoid arthritis in multiple joints and positive rheumatoid factor returns to the practice for her fourth infusion of infliximab with the nurse practitioner (NP). She reports no fevers, cough, dyspnea or concurrent illness. She rates the severity of her joint pain at 6 on a 10-point scale. The patient is currently on a non-steroidal anti-inflammatory drug (NSAID), weekly methotrexate subcutaneous injections, folic acid and famotidine. No changes were made in the patient’s medications. The patient’s weight is 130 lbs.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The patient is administered 50 mg of diphenhydramine as a prophylactic against a possible drug reaction to infliximab. Her IV line is started at 10 a.m. The intravenous infliximab 300 mg by infusion is started at 10:15 a.m. and ends at 12:26 p.m.

Is billing this service allowable under Medicare nonphysician rules?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

A. Yes
B. No
C. Maybe

Scenario 2: Incident-to Billing

A 66-year-old male patient with rheumatoid arthritis in multiple joints and positive rheumatoid factor returns to the practice for his fifth infliximab infusion with the physician assistant (PA). The rheumatologist is in the practice acting as the supervising physician. The patient reports no fevers, cough, dyspnea or concurrent illness. He rates the severity of his joint pain at 7 on a 10-point scale. The patient is currently on an NSAID and weekly methotrexate subcutaneous injections. No changes were made in the patient’s medications. The patient’s weight is 265 lbs.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The patient is administered 50 mg of diphenhydramine as a prophylactic measure against a possible drug reaction to infliximab. His IV line is started at 10 a.m. The intravenous infliximab 600 mg by infusion is started at 10:05 a.m. and ends at 11:14 a.m.

Is billing this service allowable under Medicare nonphysician rules?

A. Yes
B. No
C. Maybe

Click here for the answer(s).

Filed Under: Billing/Coding, From the College Tagged With: Medicare, nurse practitioner, physician assistantIssue: February 2020

You Might Also Like:
  • Coding Corner Answers: Using NP/PA Services in Practice
  • Coding Corner Question: March
  • Rheumatology Coding Corner Question: Infusion Services for Skilled Nursing Facility Patient
  • Coding Corner Question: July

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)